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Background: The aim of this retrospective study was to evaluate the survival of dental implants placed after
ablative surgery, in patients affected by oral cancer treated with or without radiotherapy.
Methods: We collected data for 34 subjects (22 females, 12 males; mean age: 51 ± 19) with malignant oral tumors
who had been treated with ablative surgery and received dental implant rehabilitation between 2007 and 2012.
Postoperative radiation therapy (less than 50 Gy) was delivered before implant placement in 12 patients. A total of 144
titanium implants were placed, at a minimum interval of 12 months, in irradiated and non-irradiated residual bone.
Results: Implant loss was dependent on the position and location of the implants (P = 0.05–0.1). Moreover, implant
survival was dependent on whether the patient had received radiotherapy. This result was highly statistically significant
(P < 0.01). Whether the implant was loaded is another highly significant (P < 0.01) factor determining survival. We
observed significantly better outcomes when the implant was not loaded until at least 6 months after placement.
Conclusions: Although the retrospective design of this study could be affected by selection and information biases,
we conclude that a delayed loading protocol will give the best chance of implant osseointegration, stability and,
ultimately, effective dental rehabilitation.
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Head-and-neck cancer is the most common cancer world-
wide with an estimated global incidence of 500,000 new
cases annually, three-quarters of which are in underdevel-
oped countries. The vast majority (approximately 90%) of
head-and-neck cancers are squamous cell carcinomas [1].
According to a recent review, in the United States the 5-
year survival rate of head and neck cancer is 57% [2].
Patients with oral cancer are commonly treated by a com-
bination of radiotherapy and ablative surgery. After radical
cancer surgery, the oral rehabilitation of a patient is a
demanding procedure. Following radiation and surgical
resection, most patients suffer from soft and hard tissue
defects resulting in functional disabilities and esthetic
deformity [3]. Dental rehabilitation using conventional* Correspondence: matteo.saccucci@uniroma1.it
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unless otherwise stated.prostheses may be compromised or precluded by disad-
vantageous changes in oral anatomy, and radiotherapy can
produce mucositis, xerostomia and disruption of bone
healing processes [3]. In this situation, dental implants can
potentially result in a more effective oral rehabilitation in
terms of mastication, esthetics and speech function. How-
ever, even implant treatment in oral cancer patients is
challenging because the bone into which the dental im-
plants are placed has often been within the field of irradi-
ation, or is grafted. Implant failure increases when they
are placed in irradiated bone [3], in part because radio-
therapy can result in progressive fibrosis of vessels and
soft tissue, leading to diminished healing capacity. In
addition radiations impedes the osseointegration of im-
plants by reducing bone vascularity, clinically expressed as
osteoradionecrosis. The interaction between ionizing radi-
ation and tissue causes damage to the bone, periosteum,
and connective tissue of the mucosa and the endothelium. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Patient affected by squamous cell carcinoma.
a) intraoral image of the squamous cell carcinoma,
b) ortopanoramic radiograph after ablative surgery.
Table 1 Patients and radiation characteristics
Patient Radiotherapy dose
(Gy)
Standard fractionation therapy
(2 Gy daily)/Hyperfractioned therapy
1 50 Standard fractionation therapy
2 50 Standard fractionation therapy
3 44 Standard fractionation therapy
4 48 Standard fractionation therapy
5 48 Standard fractionation therapy
6 44 Standard fractionation therapy
7 48 Standard fractionation therapy
8 44 Standard fractionation therapy
9 50 Standard fractionation therapy
10 48 Standard fractionation therapy
11 40 Standard fractionation therapy
12 50 Standard fractionation therapy
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cellularity and hypovascularity in the affected tissues, and
the loss of resistance against infection and trauma [4,5].
Tissue dehiscence and osteoradionecrosis can occur, and
often leads to implant loss. Implant treatment of irradiated
patients is dependent upon issues like the timing of im-
plant placement in relation to the radiation therapy, the
anatomic site chosen for implant placement, the radiation
dosage at that site and the consequent risk of osteoradio-
necrosis [6,7]. The aim of the present study, we evaluate
the survival of dental implants in patients affected by oral
cancer, treated with surgical and radiotherapy.
Methods
This study was conducted as a retrospective study at the
Department of Oral and Maxillofacial Science, Sapienza
University of Rome. Data were collected for a period be-
tween 2007 and 2012. The study comprised 34 subjects
(22 females, 12 males) with malignant oral tumors (22 in
the mandible/floor of the mouth, 12 in the maxilla) who
underwent dental implant rehabilitation. The patients had
undergone ablative surgery with or without adjunctive
radiation therapy. The study was approved by the Ethics
Committee at “Sapienza“ University of Rome (ref. n°
3452). All subjects gave their signed informed consent to
medical and surgical procedure and to the use of data in
this research. The mean age of the patients at the time of
surgery was 51 ± 19 years. Patients with certain systemic
disease (uncontrolled diabetes mellitus) and smokers were
excluded [8]. The most prevalent tumor diagnosed was
squamous cell carcinoma (n = 16). Other tumor types
were: ameloblastoma (n = 6); osteosarcoma (n = 4); pleo-
morphic adenoma (n = 4); fibrous dysplasia (n = 2); and
nasopharyngeal angiofibroma (n = 2). Orofacial defects in
26 patients were reconstructed microsurgically using a
range of revasculated flap techniques (Figure 1). A total of
168 titanium implants were placed in irradiated or non-
irradiated residual bone, with a minimum interval of
12 months between irradiation and implant placement.
This procedure was performed by an experienced oral
surgeon (G.P). The minimum implant length was 10 mm.
In this study, indirectly irradiated bone was considered as
non-irradiated. The time interval between radical oral
cancer surgery, radiation therapy and implant placement,
respectively, ranged from 12–89 months. After implant
placement patients underwent to a routine follow-up at
1 month, 3 months, 6 and 12 months performing an
intraoral radiograph. . Based on the histological findings,
post-operative radiotherapy was set in accordance with
the NCCN guidelines [9]. Considering this, postoperative
radiation therapy (less than 50 Gy) was delivered before
implant placement to 12 patients and was delivered in
fractions of 2 Gy given daily for 5 days each week (Table 1).
The OSSEOTITE® implants (3i Biomet, Palm BeachGardens, FL, USA) were made from commercially pure ti-
tanium (grade IV) treated with a specific, proprietary dual
acid-etching protocol. The acid-etch protocol does not in-
clude the coronal 3 mm of the titanium surface, which is
machined instead. All implants (n = 168) were placed in
jaws affected by surgical resection. There were 152 and 16
implants inserted into non irradiated and irradiated bone,
respectively. The implant primary stability was evaluated
measuring the torque at the moment of insertion. The
torque level was not superior of 40 Nm. We have planned
to use these implants as abutments for removable over-
dentures (12 patients), screw-retained fixed dentures (11
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theses (11 patients). Implant survival was evaluated within
five different subgroups: location (maxilla vs. mandible);
implant site (anterior vs. posterior); gender (male vs. fe-
male); radiotherapy (irradiated vs. non-irradiated); and
time after initial loading (immediate, <6 months, 6 months,
and >6 months) (Figure 2). Regarding the perio condi-
tions, patients were followed by an Oral Hygienist before
surgical procedures, where the patients received instruc-
tions to maintain oral health and care. The dental ele-
ments parodontally compromised were extracted as well.
After surgery an Oral Hygiene follow up was performed
every 3 months in the first year after implantation and
every 6 months thereafter. Patients were evaluated at each
review by clinical and radiographic examination. Implants
were considered to be successful when there were no pa-
tient complaints, implant mobility, peri-implantitis [7].
Survival time was measured from initial implantation to
either the failure (removal) or the last review of the im-
plant. In the present study, we considered aesthetics and
functional characteristics for each patient to optimize the
results of the final implant-prosthetic rehabilitation. WeFigure 2 Patient after implant-supported prosthesis rehabilitation.
a) implants placed in the jaw after revasculated flap reconstruction,
b) final panoramic radiograph with ossointegrated implants,
c) implant-supported prosthesis.used patients’ existing removable partial or complete den-
tures as templates for implant planning. As a conse-
quence, our implant treatment was “prosthetically driven”.
The observation mean period after radiation therapy
was 39,5 months with a standard deviation of 22,8 months.
Moreover, the mean observation period after implant
placement is 22,9 months with a SD of 15.5 months.
Statistical analysis
Implant survival was evaluated within the subgroups listed
above. The null hypothesis of independence between im-
plant survival and the various factors were tested by Pear-
son’s chi-squared test [10]. We also used Fisher’s Exact Test
[11] for count data, as the chi-squared test can be mislead-
ing when the frequency in a single cell is less than 5 units.
Results
Sixteen implants (9.5%) failed over the study period: six
during the healing phase, two during the loading phase and
eight due to recurrence of the cancer. In the mandible, 96
implants were inserted: 28 anteriorly and 68 posteriorly. In
the maxilla, 72 implants were inserted: 26 anteriorly and 46
posteriorly. In 34 patients, the initial prosthodontic treat-
ment was maintained throughout the observation period.
Two patients had recurrence of their cancer, which re-
quired a second surgical intervention during which all eight
mandibular implants were removed. Dehiscence with dis-
turbed wound healing occurred in four irradiated patients,
while dehiscence and oroantral communication was ob-
served in two irradiated patients.
The frequency and distribution of implant lost among
the population is shown in Table 2.
Descriptive analysis of these factors is shown in Tables 3,
4, 5 and 6. Overall, implant survival was not dependent on
whether the implant was placed in the maxilla or man-
dible (Table 3; p > 0.1). However, there was a significant
correlation between the rate of mandibular implant loss
and implant position, with all failing implants being in a
posterior position (Table 3; p = 0.05–0.1). In contrast,
there was no correlation in either the maxilla or the man-
dible between an implant surviving and its placement pos-
ition (Table 4; p > 0.8). Furthermore, implant survival was
significantly linked with radiotherapy (p < 0.01): implants
in non-irradiated bone predominantly survived, whereas
more implants in irradiated bone failed (Table 5). Finally,
implant survival is highly dependent on the interval period
before loading. (Table 6; p < 0.01).
Discussion
Dental implants play a crucial role in the therapy of pa-
tients affected by malignancies in the head-and-neck re-
gion. The goal of implant rehabilitation is to improve the
quality of life of these patients by allowing proper reten-
tion of removable prostheses and a reduction in the load
Table 2 Frequency and distribution of implant lost
among the population
Less 30 30 - 60 More 60 Total
Frequency
F 0 0 10 10
M 0 2 4 6
Total 0 2 14 16
Percentage
F 0,0% 0,0% 62,5% 62,5%
M 0,0% 12,5% 25,0% 37,5%
Total 0,0% 12,5% 87,5% 100,0%
Table 4 Survived implants by location (mandible, maxilla)
and position (anterior, posterior)
Anterior Posterior Total
Mandible 28 56 84
Maxilla 24 44 68
Total 52 100 152
Anterior Posterior Total
Mandible 18,40% 36,80% 55,30%
Maxilla 15,80% 28,90% 44,70%
Total 34,20% 65,80% 100,00%
Odds ratio: 0.9171932 p-value = 0.8641.
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ence implant survival, especially when patients undergo
surgical removal of the malignancies. Indeed, the experi-
ence of the surgeon, bone quality, and technical aspects
such as implant length, diameter and primary stability
each play pivotal roles. After oral cancer surgery, add-
itional factors influence implant osseointegration, such as
bone topography and applied radiation dose [13]. More-
over, poor general health, diminished oral hygiene, smok-
ing and alcohol abuse all reduce implant survival.
Radiation therapy is often the first line of therapy for
patients with head and neck cancer and is often used as
an adjunct to surgical excision. There are three different
types of radiotherapy: external beam radiation, brachy-
therapy, and radioisotope therapy. For the treatment of
head-and-neck cancer, external beam methods are most
commonly used [13]. Radiation guidelines are variable
depending on the method of radiotherapy selected as
well as the type, location, and stage of the cancer. Thera-
peutic radiation protocols for head-and-neck tumors
commonly consist of 50–70 Gy [14]. Usually, the radi-
ation dose is given in fractions of ≈ 2 Gy given either
once a day (standard fractionation therapy) or twice a
day (hyperfractionated therapy) for a defined time
period. According to Anderson et al., fractions can be
administered every day for 25 days or for 5 days a week
for a 5–7-week period [15].Table 3 Implants by survival (yes or no) and location
(mandible, maxilla), Odds ratio: 0.4137915, p-value = 0.1845
Mandible Maxilla Total
Yes 84 (50,0%) 68 (40,5%) 152 (90,5%)
No 12 (7,1%) 4 (2,4%) 16 (9,5%)
Total 96 (57,1%) 72 (42,9%) 168 (100,0%)
Anterior 0 2 2
Posterior 12 2 14
Total 12 4 16
Odds ratio: 0.4137915, p-value = 0.1845.
Below, lost implants by location (mandible, maxilla) and position (anterior, posterior).
Odds ratio = 0 p-value = 0.05.Our results indicate that implant survival is strongly
influenced by radiotherapy, confirming previous findings
[16] demonstrating that radiotherapy is an important
factor in implant failure. Ihde et al. [17] report that im-
plant failure is a more significant risk (up to 12 times
greater) in irradiated bone rather than in non-irradiated
bone. Yerit et al. [4], using a comparable protocol of ir-
radiation to that used here, found that mandibular im-
plants were significantly less likely to survive in
irradiated bone than in non-irradiated bone.
Although our findings indicate that radiotherapy is an
important factor in implant failure, the impact of the
position of implant placement within irradiated bone re-
mains contentious. There is much variation in the re-
ported success rates of implant rehabilitation. Recently,
De La Plata et al. [3] reported that the overall 5-year
survival rate in irradiated patients was 92.6%, although
irradiated patients had a slightly but significantly higher
rate of implant loss than non-irradiated patients. Linsen
et al. [13] reported implant success rates of over 89% in
irradiated bone at 1-, 5-, and 10-year follow-up. How-
ever, although these findings suggest a smaller influence
of radiation on implant survival than we found here, this
discrepancy may be explained by differences between
their radiation protocol and our own.
Dosage protocol is a crucial factor with regard to radi-
ation therapy. There is no literature consensus regardingTable 5 Implants by survival (yes or no) and radiotherapy
(not irradiated, irradiated bone)
Not irradiated Irradiated Total
Yes 113 39 152
No 4 12 16
Total 117 51 168
Not irradiated Irradiated Total
Yes 67,30% 23,20% 90,50%
No 2,40% 7,10% 9,50%
Total 69,60% 30,40% 100,00%
Odds ratio: 8.561084 p-value = 0.0001423.
Table 6 Implants by survival (yes or no) and number of implants loaded at different time (immediate, less than
6 months, 6 months, more than 6 months)
Immediate Less than 6 months 6 months More than 6 months Total
Yes 44 17 52 39 152
No 4 8 4 0 16
Total 48 25 56 39 168
Immediate Less than 6 months 6 months More than 6 months Total
Yes 26,20% 10,10% 31,00% 23,20% 90,50%
No 2,40% 4,80% 2,40% 0,00% 9,50%
Total 28,60% 14,90% 33,30% 23,20% 100,00%
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ence increased risk of failure. Indeed, Javed et al. [18]
observed that dental implants showed up to 100%
osseointegration when exposed to radiation dosages up
to 65 Gy, and suggested that radiation dosages between
50–65 Gy do not negatively influence osseointegration.
Conversely, several authors [4,19,20] concluded that a
total dose less than 50 Gy is necessary to minimize the
negative effects of radiotherapy. In conclusion, it seems
realistic to assume that full-course radiotherapy (50–
65 Gy) is not an absolute contraindication to implant
surgery, but that determination of the absolute risk of
implant survival must take into account the other con-
tributory factors, as described here.
The optimal timing of implant placement in radio-
therapy patients is controversial [21]. Some authors rec-
ommend the insertion of implants following the ablative
procedure [21-24]. This is advantageous because initial
implant healing (osseointegration) takes place before ir-
radiation and there is a reduced risk of late complica-
tions, such as the development of osteoradionecrosis
[20-22]. However, there is a risk of inappropriate im-
plant positioning, which makes subsequent prosthodon-
tic treatment more complex [13,18,19]. There is also a
risk that early tumor recurrence will negate the benefits
of the implant therapy [25]. In this study, we opted for
delayed implant insertion to avoid these complications.
However, there is also little consensus on the optimal
time interval between irradiation and implant place-
ment. Although implant placement is performed gener-
ally no earlier than 6 months after irradiation,
Ganström et al. suggest that implant therapy should be
complete by 6–18 months after radiation [19]. However,
Sammartino et al. [8] recommend waiting at least
12 months to achieve the best clinical results. It is im-
portant to note that the risk of osteoradionecrosis after
radiotherapy in head-and-neck cancer patients does not
diminish over time because it is underpinned by the
progressive and irreversible loss of capillaries [16].
Moreover, immediate implant insertion can be problem-
atic because ablative surgery alters bone anatomy exten-
sively. In our study, the time interval from radical oralcancer surgery through radiation therapy until implant
placement ranged from 11–89 months (mean: 39.58).
For the rehabilitative implant-supported prosthesis, we
aimed to achieve group function as an occlusal scheme
and no mucosal contact, to minimize the risk of mucosal
complications. The reduction of mucosal contact is im-
portant because fragile mucosa and severe mucositis are
common manifestations observed long after radiation
therapy. This increases the risk that prosthetic pressure
lesions will result in septic osteoradionecrosis [26,27].
There was a highly significant relationship between the
time of loading and the success of the implant in irradi-
ated bone. Good results were obtained with an implant
loading protocol of 6 months, and no implants were lost
when the period of healing was greater than 6 months.
These data support those of Dholam et al. [28], who
commented on the importance of bone healing and the
slow rate of osseointegration in irradiated bone. These
data thus do not support immediate loading [28], and
we would recommend a period of 6 months or more be-
fore loading implants in irradiated bone.
We found no relationship between implant survival and
the location of placement (maxilla vs. mandible). We did
find a stark discrepancy in implant failure in terms of po-
sitioning. Implants in the posterior mandible were much
more frequently lost than in other positions. This finding
is in disagreement with the conclusions of a recent review
[20] that reported better outcomes in the mandible. We
are unclear why this contradiction occurred. Regarding
the influence of prosthetic rehabilitation on implants sur-
vivals, it is important to underline that no standard pros-
thetic appliance is described in the literature. This is due
to the large interindividual variability regarding the topog-
raphy and dimension of the defects. Nevertheless, in this
study as well as in a previous study [8] no specific super-
structure was found to be particularly favorable in terms
of implant survival.
Conclusions
Irradiated bone is a challenging environment for im-
plant placement. Successful rehabilitation of irradi-
ated patients with implant-supported prostheses is
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this study could be affected by selection and informa-
tion biases our results, leads us to believe that imme-
diate [29] and progressive [30] loading protocols are
not advisable in irradiated patients. We conclude that
a delayed loading protocol will give the best chance of
implant osseointegration, stability and, ultimately, ef-
fective dental rehabilitation.
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